MSI-78 topical anti-infective: Entered pivotal Phase IIb/III trial

Magainin Pharmaceuticals Inc. (MAGN) Product: MSI-78 topical anti-infective Indication: Impetigo Status: Entered pivotal Phase IIb/III trial in 280 patients. MAGN plans a second pivotal trial but did...